C. Petropoulos

Antiretroviral resistance during successful therapy of HIV type 1 infection

Javier Martínez‐Picado, Maria Pia DePasquale, Nicholas A. Kartsonis et al. · Proceedings of the National Academy of Sciences · 2000 · 210 citations · Full text

Residual Virus Replication, Drug Resistance Mutations, Treatment And Prevention +12

Changes in Human Immunodeficiency Virus Type 1 Gag at Positions L449 and P453 Are Linked to I50V Protease Mutants In Vivo and Cause Reduction of Sensitivity to Amprenavir and Improved Viral Fitness In Vitro

Michael Maguire, Rosario Guinea, Philip Griffin et al. · Journal of Virology · 2002 · 157 citations · Full text

Viral Replication, Immunology, I50v Protease Mutants +18

Magnitude and Breadth of a Nonprotective Neutralizing Antibody Response in an Efficacy Trial of a Candidate HIV‐1 gp120 Vaccine

Peter B. Gilbert, Maggie Haitian Wang, Terri Wrin et al. · The Journal of Infectious Diseases · 2010 · 128 citations · Full text

Mutation D30N Is Not Preferentially Selected by Human Immunodeficiency Virus Type 1 Subtype C in the Development of Resistance to Nelfinavir

Zehava Grossman, Ellen E. Paxinos, Diana Averbuch et al. · Antimicrobial Agents and Chemotherapy · 2004 · 117 citations · Full text

Primary Immunodeficiency, Human Retrovirus, Pathogenesis +13

Natural Variation of Drug Susceptibility in Wild-Type Human Immunodeficiency Virus Type 1

Neil Parkin, Nicholas S. Hellmann, Jeannette M. Whitcomb et al. · Antimicrobial Agents and Chemotherapy · 2004 · 110 citations · Full text